Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Walt Disney
DIS
|
$1.13B |
| 2 |
UnitedHealth
UNH
|
$379M |
| 3 |
Meta Platforms (Facebook)
META
|
$325M |
| 4 |
Wabtec
WAB
|
$303M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$216M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$558M |
| 2 |
Coca-Cola
KO
|
$358M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
$326M |
| 4 |
ATHN
Athenahealth, Inc.
ATHN
|
$323M |
| 5 |
Starbucks
SBUX
|
$312M |
Sector Composition
| 1 | Technology | 24.08% |
| 2 | Healthcare | 17.92% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intuitive Surgical
ISRG
$170B
| $1.02B | 0.56% | 1,785,350 -42,932 | -2% | -$24.5M |
|
27
CoStar Group
CSGP
$37.9B
| $990M | 0.55% | 2,123,448 -283,175 | -12% | -$132M |
|
28
NVIDIA
NVDA
$4.24T
| $975M | 0.54% | 5,430,170 -578,282 | -10% | -$104M |
|
29
CSX Corp
CSX
$60.6B
| $967M | 0.54% | 12,929,434 +60,234 | +0.5% | +$4.51M |
|
30
Intuit
INTU
$186B
| $965M | 0.54% | 3,692,449 -107,334 | -3% | -$28.1M |
|
31
Humana
HUM
$36.5B
| $957M | 0.53% | 3,596,204 +120,905 | +3% | +$32.2M |
|
32
Lam Research
LRCX
$127B
| $952M | 0.53% | 5,319,626 -123,329 | -2% | -$22.1M |
|
33
Progressive
PGR
$145B
| $948M | 0.53% | 13,147,056 +374,526 | +3% | +$27M |
|
34
Microchip Technology
MCHP
$35.1B
| $899M | 0.5% | 10,833,329 -1,027,792 | -9% | -$85.3M |
|
35
Intercontinental Exchange
ICE
$101B
| $897M | 0.5% | 11,776,528 +333,709 | +3% | +$25.4M |
|
36
Nike
NKE
$114B
| $896M | 0.5% | 10,641,125 -592,287 | -5% | -$49.9M |
|
37
Steris
STE
$24.1B
| $890M | 0.49% | 6,951,858 -298,453 | -4% | -$38.2M |
|
38
Alphabet (Google) Class A
GOOGL
$2.57T
| $883M | 0.49% | 750,117 +10,686 | +1% | +$12.6M |
|
39
American Tower
AMT
$95.5B
| $880M | 0.49% | 4,465,470 +296,836 | +7% | +$58.5M |
|
|
AGN
40
DELISTED
Allergan plc
AGN
| $857M | 0.48% | 5,855,576 +1,265,742 | +28% | +$185M |
|
41
Cooper Companies
COO
$13.4B
| $839M | 0.47% | 2,834,318 +112,906 | +4% | +$33.4M |
|
42
Gartner
IT
$19B
| $820M | 0.45% | 5,408,961 +15,604 | +0.3% | +$2.37M |
|
43
Broadridge
BR
$29.9B
| $811M | 0.45% | 7,824,319 +1,177,867 | +18% | +$122M |
|
44
L3Harris
LHX
$51.9B
| $811M | 0.45% | 5,078,411 +652,182 | +15% | +$104M |
|
45
AbbVie
ABBV
$372B
| $807M | 0.45% | 10,007,634 +887,231 | +10% | +$71.5M |
|
46
Neurocrine Biosciences
NBIX
$13.8B
| $776M | 0.43% | 8,811,961 +4,547 | +0.1% | +$401K |
|
47
Verisk Analytics
VRSK
$37.5B
| $765M | 0.42% | 5,754,168 -61,610 | -1% | -$8.19M |
|
48
Alibaba
BABA
$322B
| $761M | 0.42% | 4,173,427 -29,349 | -0.7% | -$5.35M |
|
49
PayPal
PYPL
$67.1B
| $742M | 0.41% | 7,146,346 +156,166 | +2% | +$16.2M |
|
50
WEX
WEX
$5.87B
| $731M | 0.41% | 3,809,094 +13,441 | +0.4% | +$2.58M |
|